Rafael Holdings, Inc. owns commercial real estate assets and interests in clinical pharmaceutical companies. The company operates in two segments, Real Estate and Pharmaceuticals. It engages in the lease of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.